The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies
Open accessAbstract
Resistance to therapy is the major hurdle in the current cancer management. Cancer cells often rewire their cellular process to alternate mechanisms to resist the deleterious effect mounted by different therapeutic approaches. The major signaling pathways involved in the developmental process, such as Notch, Hedgehog, and Wnt, play a vital role in development, tumorigenesis, and also in the resistance to the various anticancer therapies. Understanding how cancer utilizes these developmental pathways in acquiring the resistance to the multi-therapeutic approach cancer can give rise to a new insight of the anti-therapy resistance mechanisms, which can be explored for the development of a novel therapeutic approach. We present a brief overview of Notch, Hedgehog, and Wnt signaling pathways in cancer and its role in providing resistance to various cancer treatment modalities such as chemotherapy, radiotherapy, molecular targeted therapy, and immunotherapy. Understanding the importance of these molecular networks will provide a rational basis for novel and safer combined anticancer therapeutic approaches for the improvement of cancer treatment by overcoming drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-κB Activation
Li, L., Zhao, F., Lü, J., Li, T., Yang, H., Wu, C., & Liu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095912 · Cited by 97
RetractedMutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830
A view on drug resistance in cancer
Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., & Sklar, J. (1991) · Cell · doi:10.1016/0092-8674(91)90111-b · Cited by 1,696
The complex world of WNT receptor signalling
Niehrs, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3470 · Cited by 1,492
Targeting the Wnt/β-catenin signaling pathway in cancer
Zhang, Y., & Wang, X. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00990-3 · Cited by 1,431
The cellular and molecular origin of tumor-associated macrophages
Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., Pamer, E. G., & Li, M. O. (2014) · Science · doi:10.1126/science.1252510 · Cited by 1,393
Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors
Gordon, M. D., & Nusse, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600015200 · Cited by 1,333
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Krishnamurthy, N., & Kurzrock, R. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.002 · Cited by 1,026
Notch Signaling in Development, Tissue Homeostasis, and Disease
Siebel, C., & Lendahl, U. (2017) · Physiological Reviews · doi:10.1152/physrev.00005.2017 · Cited by 978
Notch signalling regulates stem cell numbers in vitro and in vivo
Androutsellis-Theotokis, A., Leker, R. R., Soldner, F., Hoeppner, D. J., Ravin, R., Poser, S. W., Rueger, M. A., Bae, S.-K., Kittappa, R., & McKay, R. D. G. (2006) · Nature · doi:10.1038/nature04940 · Cited by 956
Notch signalling in solid tumours: a little bit of everything but not all the time
Ranganathan, P., Weaver, K. L., & Capobianco, A. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3035 · Cited by 824
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Boelens, M. C., Wu, T. J., Nabet, B. Y., Xu, B., Qiu, Y., Yoon, T., Azzam, D. J., Twyman-Saint Victor, C., Wiemann, B. Z., Ishwaran, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.051 · Cited by 806
Wnt/β-catenin signaling in cancer stemness and malignant behavior
Fodde, R., & Brabletz, T. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.007 · Cited by 785
Clara, J. A., Monge, C., Yang, Y., & Takebe, N. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752
WNT/β-catenin pathway activation correlates with immune exclusion across human cancers
Luke, J. J., Bao, R., Sweis, R. F., Spranger, S., & Gajewski, T. F. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1942 · Cited by 722
Wnt Signaling Requires Sequestration of Glycogen Synthase Kinase 3 inside Multivesicular Endosomes
Taelman, V. F., Dobrowolski, R., Plouhinec, J.-L., Fuentealba, L. C., Vorwald, P. P., Gumper, I., Sabatini, D. D., & De Robertis, E. M. (2010) · Cell · doi:10.1016/j.cell.2010.11.034 · Cited by 676
Modulating ROS to overcome multidrug resistance in cancer
Cui, Q., Wang, J.-Q., Assaraf, Y. G., Ren, L., Gupta, P., Wei, L., Ashby, C. R., Yang, D.-H., & Chen, Z.-S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.11.001 · Cited by 661
Notch Promotes Radioresistance of Glioma Stem Cells
Wang, J., Wakeman, T. P., Lathia, J. D., Hjelmeland, A. B., Wang, X.-F., White, R. R., Rich, J. N., & Sullenger, B. A. (2010) · Stem Cells · doi:10.1002/stem.261 · Cited by 656
Wang, Z., Li, Y., Kong, D., Banerjee, S., Ahmad, A., Azmi, A. S., Ali, S., Abbruzzese, J. L., Gallick, G. E., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4312 · Cited by 619
WNT signalling in the immune system: WNT is spreading its wings
Staal, F. J. T., Luis, T. C., & Tiemessen, M. M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2360 · Cited by 582
Casein kinase 1 γ couples Wnt receptor activation to cytoplasmic signal transduction
Davidson, G., Wu, W., Shen, J., Bilic, J., Fenger, U., Stannek, P., Glinka, A., & Niehrs, C. (2005) · Nature · doi:10.1038/nature04170 · Cited by 581
Hori, K., Sen, A., & Artavanis-Tsakonas, S. (2013) · Journal of Cell Science · doi:10.1242/jcs.127308 · Cited by 571
BET inhibitor resistance emerges from leukaemia stem cells
Fong, C. Y., Gilan, O., Lam, E. Y. N., Rubin, A. F., Ftouni, S., Tyler, D., Stanley, K., Sinha, D., Yeh, P., Morison, J., et al. (2015) · Nature · doi:10.1038/nature14888 · Cited by 545
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
Rathert, P., Roth, M., Neumann, T., Muerdter, F., Roe, J.-S., Muhar, M., Deswal, S., Cerny-Reiterer, S., Peter, B., Jude, J., et al. (2015) · Nature · doi:10.1038/nature14898 · Cited by 499
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
Bonilla, X., Parmentier, L., King, B., Bezrukov, F., Kaya, G., Zoete, V., Seplyarskiy, V. B., Sharpe, H. J., McKee, T., Letourneau, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3525 · Cited by 490
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
Lim, J. S., Ibaseta, A., Fischer, M. M., Cancilla, B., O’Young, G., Cristea, S., Luca, V. C., Yang, D., Jahchan, N. S., Hamard, C., et al. (2017) · Nature · doi:10.1038/nature22323 · Cited by 485
Kenney, A. M., Cole, M. D., & Rowitch, D. H. (2003) · Development · doi:10.1242/dev.00182 · Cited by 477
Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors
Levanon, D., Goldstein, R. E., Bernstein, Y., Tang, H., Goldenberg, D., Stifani, S., Paroush, Z., & Groner, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11590 · Cited by 468
Therapeutic modulation of Notch signalling — are we there yet?
Andersson, E. R., & Lendahl, U. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4252 · Cited by 457
The many facets of Notch ligands
D'Souza, B., Miyamoto, A., & Weinmaster, G. (2008) · Oncogene · doi:10.1038/onc.2008.229 · Cited by 438
Cazet, A. S., Hui, M. N., Elsworth, B. L., Wu, S. Z., Roden, D., Chan, C.-L., Skhinas, J. N., Collot, R., Yang, J., Harvey, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05220-6 · Cited by 437
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
Takebe, N., Nguyen, D., & Yang, S. X. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.005 · Cited by 413
Trujillo, J. A., Sweis, R. F., Bao, R., & Luke, J. J. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0277 · Cited by 393
Zhou, C., Yi, C., Yi, Y., Qin, W., Yan, Y., Dong, X., Zhang, X., Huang, Y., Zhang, R., Wei, J., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01237-y · Cited by 382
Structural basis for autoinhibition of Notch
Gordon, W. R., Vardar-Ulu, D., Histen, G., Sanchez-Irizarry, C., Aster, J. C., & Blacklow, S. C. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1227 · Cited by 372
Nowell, C. S., & Radtke, F. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.145 · Cited by 369
All Tcf HMG box transcription factors interact with Groucho-related co-repressors
Brantjes, H. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.7.1410 · Cited by 361
Differential transformation of mammary epithelial cells by Wnt genes.
Wong, G. T., Gavin, B. J., & McMahon, A. P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.6278 · Cited by 339
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
McAuliffe, S. M., Morgan, S. L., Wyant, G. A., Tran, L. T., Muto, K. W., Chen, Y. S., Chin, K. T., Partridge, J. C., Poole, B. B., Cheng, K.-H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206400109 · Cited by 328
Qiang, L., Wu, T., Zhang, H.-W., Lu, N., Hu, R., Wang, Y.-J., Zhao, L., Chen, F.-H., Wang, X.-T., You, Q.-D., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.95 · Cited by 313
Rosati, E., Sabatini, R., Rampino, G., Tabilio, A., Di Ianni, M., Fettucciari, K., Bartoli, A., Coaccioli, S., Screpanti, I., & Marconi, P. (2009) · Blood · doi:10.1182/blood-2008-02-139725 · Cited by 302
Kopan, R. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011213 · Cited by 294
Petty, A. J., Li, A., Wang, X., Dai, R., Heyman, B., Hsu, D., Huang, X., & Yang, Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128644 · Cited by 287
WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
Martin-Orozco, E., Sanchez-Fernandez, A., Ortiz-Parra, I., & Ayala-San Nicolas, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02854 · Cited by 286
Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights
Patel, S., Alam, A., Pant, R., & Chattopadhyay, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02872 · Cited by 285
Notch post-translationally regulates β-catenin protein in stem and progenitor cells
Kwon, C., Cheng, P., King, I. N., Andersen, P., Shenje, L., Nigam, V., & Srivastava, D. (2011) · Nature Cell Biology · doi:10.1038/ncb2313 · Cited by 284
Tang, Y.-A., Chen, Y.-F., Bao, Y., Mahara, S., Yatim, S. M. J. M., Oguz, G., Lee, P. L., Feng, M., Cai, Y., Tan, E. Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801348115 · Cited by 277
Self-citationEpithelial-Mesenchymal Transition in tumor microenvironment
Jing, Y., Han, Z., Zhang, S., Liu, Y., & Wei, L. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-29 · Cited by 270
Polytherapy and Targeted Cancer Drug Resistance
Chatterjee, N., & Bivona, T. G. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.02.003 · Cited by 270
New Insights into the Mechanism of Wnt Signaling Pathway Activation
(2011) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-386035-4.00002-1 · Cited by 260
Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia
Piovan, E., Yu, J., Tosello, V., Herranz, D., Ambesi-Impiombato, A., Da Silva, A. C., Sanchez-Martin, M., Perez-Garcia, A., Rigo, I., Castillo, M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.022 · Cited by 256
Li, B., Cao, Y., Meng, G., Qian, L., Xu, T., Yan, C., Luo, O., Wang, S., Wei, J., Ding, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.063 · Cited by 245
Non-canonical Notch signaling: emerging role and mechanism
Andersen, P., Uosaki, H., Shenje, L. T., & Kwon, C. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.02.003 · Cited by 238
Li, Q., Lai, Q., He, C., Fang, Y., Yan, Q., Zhang, Y., Wang, X., Gu, C., Wang, Y., Ye, L., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1330-9 · Cited by 232
Cao, Z., Ding, B.-S., Guo, P., Lee, S. B., Butler, J. M., Casey, S. C., Simons, M., Tam, W., Felsher, D. W., Shido, K., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.005 · Cited by 223
Long, G. V., Eroglu, Z., Infante, J., Patel, S., Daud, A., Johnson, D. B., Gonzalez, R., Kefford, R., Hamid, O., Schuchter, L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.1025 · Cited by 221
Mamaeva, V., Rosenholm, J. M., Bate-Eya, L. T., Bergman, L., Peuhu, E., Duchanoy, A., Fortelius, L. E., Landor, S., Toivola, D. M., Lindén, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.105 · Cited by 220
Joshi, I., Minter, L. M., Telfer, J., Demarest, R. M., Capobianco, A. J., Aster, J. C., Sicinski, P., Fauq, A., Golde, T. E., & Osborne, B. A. (2009) · Blood · doi:10.1182/blood-2008-03-147967 · Cited by 213
Wall, D. S., Mears, A. J., McNeill, B., Mazerolle, C., Thurig, S., Wang, Y., Kageyama, R., & Wallace, V. A. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200805155 · Cited by 208
Wnt–Notch signalling crosstalk in development and disease
Collu, G. M., Hidalgo-Sastre, A., & Brennan, K. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1644-x · Cited by 198
Zweidler-McKay, P. A., He, Y., Xu, L., Rodriguez, C. G., Karnell, F. G., Carpenter, A. C., Aster, J. C., Allman, D., & Pear, W. S. (2005) · Blood · doi:10.1182/blood-2005-01-0355 · Cited by 193
β-Catenin Regulation during the Cell Cycle: Implications in G2/M and Apoptosis
Olmeda, D., Castel, S., Vilaró, S., & Cano, A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-01-0865 · Cited by 191
Precision medicine for human cancers with Notch signaling dysregulation (Review)
Katoh, M., & Katoh, M. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4418 · Cited by 191
Flahaut, M., Meier, R., Coulon, A., Nardou, K. A., Niggli, F. K., Martinet, D., Beckmann, J. S., Joseph, J.-M., Mühlethaler-Mottet, A., & Gross, N. (2009) · Oncogene · doi:10.1038/onc.2009.80 · Cited by 190
LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis
Galceran, J., Sustmann, C., Hsu, S.-C., Folberth, S., & Grosschedl, R. (2004) · Genes & Development · doi:10.1101/gad.1249504 · Cited by 184
Holtzhausen, A., Zhao, F., Evans, K. S., Tsutsui, M., Orabona, C., Tyler, D. S., & Hanks, B. A. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0167 · Cited by 180
Patched1 Functions as a Gatekeeper by Promoting Cell Cycle Progression
Adolphe, C., Hetherington, R., Ellis, T., & Wainwright, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2146 · Cited by 178
Athar, M., Li, C., Tang, X., Chi, S., Zhang, X., Kim, A. L., Tyring, S. K., Kopelovich, L., Hebert, J., Epstein, E. H., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1393 · Cited by 172
Crosstalk between the Androgen Receptor and β-Catenin in Castrate-Resistant Prostate Cancer
Wang, G., Wang, J., & Sadar, M. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1718 · Cited by 168
Schreck, K. C., Taylor, P., Marchionni, L., Gopalakrishnan, V., Bar, E. E., Gaiano, N., & Eberhart, C. G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1624 · Cited by 167
Li, Y., Hibbs, M. A., Gard, A. L., Shylo, N. A., & Yun, K. (2012) · Stem Cells · doi:10.1002/stem.1030 · Cited by 164
Non-Canonical Notch Signaling in Cancer and Immunity
Ayaz, F., & Osborne, B. A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00345 · Cited by 163
Yan, Y., Liu, F., Han, L., Zhao, L., Chen, J., Olopade, O. I., He, M., & Wei, M. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0925-x · Cited by 160
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance
Pothuraju, R., Rachagani, S., Krishn, S. R., Chaudhary, S., Nimmakayala, R. K., Siddiqui, J. A., Ganguly, K., Lakshmanan, I., Cox, J. L., Mallya, K., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01156-y · Cited by 160
Gli1 acts through Snail and E-cadherin to promote nuclear signaling by β-catenin
Li, X., Deng, W., Lobo-Ruppert, S. M., & Ruppert, J. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210241 · Cited by 155
Suppressing Wnt Signaling by the Hedgehog Pathway through sFRP-1
He, J., Sheng, T., Stelter, A. A., Li, C., Zhang, X., Sinha, M., Luxon, B. A., & Xie, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600200200 · Cited by 149
A phase II study of RO4929097 in metastatic colorectal cancer
Strosberg, J., Yeatman, T. J., Weber, J., Coppola, D., Schell, M. J., Han, G., Almhanna, K., Kim, R. D., Valone, T., Jump, H., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.056 · Cited by 148
Fukushima, N., Minami, Y., Kakiuchi, S., Kuwatsuka, Y., Hayakawa, F., Jamieson, C., Kiyoi, H., & Naoe, T. (2016) · Cancer Science · doi:10.1111/cas.13019 · Cited by 145
Notch-Nrf2 Axis: Regulation of Nrf2 Gene Expression and Cytoprotection by Notch Signaling
Wakabayashi, N., Skoko, J., Chartoumpekis, D. V., Kimura, S., Slocum, S. L., Noda, K., Palliyaguru, D. L., Fujimuro, M., Boley, P. A., Tanaka, Y., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01408-13 · Cited by 141
Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells
Perry, J. M., Fang, T., Roy, A., Lin, T. L., He, X., Chen, S., Lü, X., Nemechek, J. M., Ruan, L., Yu, X., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0507-y · Cited by 141
Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer
Kim, H.-A., Koo, B.-K., Cho, J.-H., Kim, Y.-Y., Seong, J., Chang, H. J., Oh, Y. M., Stange, D. E., Park, J.-G., Hwang, D., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61216 · Cited by 139
Notch3 and pre‐TCR interaction unveils distinct NF‐κB pathways in T‐cell development and leukemia
Vacca, A., Felli, M. P., Palermo, R., Mario, G. D., Calce, A., Giovine, M. D., Frati, L., Gulino, A., & Screpanti, I. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600996 · Cited by 138
Wnt Signaling Stimulates Transcriptional Outcome of the Hedgehog Pathway by Stabilizing GLI1 mRNA
Noubissi, F. K., Goswami, S., Sanek, N. A., Kawakami, K., Minamoto, T., Moser, A. R., Grinblat, Y., & Spiegelman, V. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1500 · Cited by 136
Cook, N., Basu, B., Smith, D. M., Gopinathan, A., Evans, J., Steward, W. P., Palmer, D. H., PROPPER, D. J., Venugopal, B., Hategan, M., et al. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.495 · Cited by 129
Inhibitory Gli3 Activity Negatively Regulates Wnt/β-Catenin Signaling
Ulloa, F., Itasaki, N., & Briscoe, J. (2007) · Current Biology · doi:10.1016/j.cub.2007.01.062 · Cited by 128
Clappier, E., Collette, S., Grardel, N., Girard, S., Suarez, L., Brunie, G., Kaltenbach, S., Yakouben, K., Mazingue, F., Robert, A., et al. (2010) · Leukemia · doi:10.1038/leu.2010.205 · Cited by 128
Della Corte, C. M., Bellevicine, C., Vicidomini, G., Vitagliano, D., Malapelle, U., Accardo, M., Fabozzi, A., Fiorelli, A., Fasano, M., Papaccio, F., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3319 · Cited by 122
Zhang, K., Hong, X., Song, Z., Xu, Y., Li, C., Wang, G., Zhang, Y., Zhao, X., Zhao, Z., Zhao, J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3976 · Cited by 122
Mamaeva, V., Niemi, R., Beck, M., Özliseli, E., Desai, D., Landor, S. K.-J., Grönroos, T. J., Kronqvist, P., Pettersen, I. K. N., McCormack, E., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.42 · Cited by 120
LIG4 mediates Wnt signalling-induced radioresistance
Jun, S., Jung, Y., Suh, H. N., Wang, W., Kim, M. J., Oh, Y. S., Lien, E. M., Shen, X. H., Matsumoto, Y., McCrea, P. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10994 · Cited by 119
Ma, Y., Ren, Y., Han, E. Q., Li, H., Chen, D., Jacobs, J. J., Gitelis, S., O’Keefe, R. J., Konttinen, Y. T., Yin, G., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.118 · Cited by 117
Eiraku, M., Hirata, Y., Takeshima, H., Hirano, T., & Kengaku, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110793200 · Cited by 117
Targeting cancer stem cells in drug discovery: Current state and future perspectives
Du, F., Zhou, Q., Sun, W., & Chen, G. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i7.398 · Cited by 117
Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential
Spaan, I., Raymakers, R. A. P., van de Stolpe, A., & Peperzak, V. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0615-3 · Cited by 115
Bora-Singhal, N., Perumal, D., Nguyen, J. V., & Chellappan, S. (2015) · Neoplasia · doi:10.1016/j.neo.2015.07.001 · Cited by 110
Baker, A. T., Wyatt, D. L., Bocchetta, M., Li, J., Filipović, A., Green, A. R., Peiffer, D. S., Fuqua, S. A. W., Miele, L., Albain, K. S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0251-y · Cited by 108
Chen, G., Gao, C., Gao, X., Zhang, D. H., Kuan, S.-F., Burns, T. F., & Hu, J. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0561 · Cited by 104
Faião‐Flores, F., Alves-Fernandes, D. K., Pennacchi, P. C., Sandri, S., Vicente, A. L. S. A., Scapulatempo‐Neto, C., Vazquez, V. D. L., Reis, R. M., Chauhan, J. S., Goding, C. R., et al. (2016) · Oncogene · doi:10.1038/onc.2016.348 · Cited by 104
Stasiulewicz, M., Gray, S., Mastromina, I., Silva, J. C., Bjorklund, M., Seymour, P. A., Booth, D. B., Thompson, C., Green, R., Hall, E. A., et al. (2015) · Development · doi:10.1242/dev.125237 · Cited by 101
Zhao, Y., Lu, Q., Li, C., Wang, X., Jiang, L., Huang, L. F., Wang, C., & Chen, H. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1595-0 · Cited by 101
Hu, Y., Yu, K., Wang, G., Zhang, D., Shi, C., Ding, Y., Hong, D., Zhang, D., He, H., Sun, L., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.023 · Cited by 98
Wnt/Beta-Catenin Signaling and Prostate Cancer Therapy Resistance
Yeh, Y. A., Guo, Q., Connelly, Z. M., Cheng, S., Yang, S., Prieto‐Domínguez, N., & Yu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_16 · Cited by 98
Keysar, S. B., Le, P. N., Anderson, R. T., Morton, J. J., Bowles, D. W., Paylor, J. J., Vogler, B. W., Thorburn, J., Fernandez, P., Glogowska, M. J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4047 · Cited by 97
Usui, T., Sakurai, M., Umata, K., Elbadawy, M., Ohama, T., Yamawaki, H., Hazama, S., Takenouchi, H., Nakajima, M., Tsunedomi, R., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041098 · Cited by 96
Yao, J., & Qian, C. (2009) · Medical Oncology · doi:10.1007/s12032-009-9326-5 · Cited by 95
Notch is a direct negative regulator of the DNA-damage response
Vermezovic, J., Adamowicz, M., Santarpia, L., Rustighi, A., Forcato, M., Lucano, C., Massimiliano, L., Costanzo, V., Bicciato, S., Sal, G. D., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3013 · Cited by 95
Zhang, Z.-M., Wu, J.-F., Luo, Q.-C., Liu, Q.-F., Wu, Q.-W., Ye, G., She, H.-Q., & Li, B.-A. (2016) · Oncogene · doi:10.1038/onc.2016.10 · Cited by 95
Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models
Zhang, C. C., Yan, Z., Zong, Q., et al. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0096 · Cited by 94
Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling
Taylor, M. D., Zhang, X., Liu, L., Hui, C., Mainprize, T. G., Scherer, S. W., Wainwright, B. J., Hogg, D., & Rutka, J. T. (2004) · Oncogene · doi:10.1038/sj.onc.1207605 · Cited by 92
Phase 2 study of RO 4929097, a gamma‐secretase inhibitor, in metastatic melanoma: SWOG 0933
Lee, S. M., Moon, J., Redman, B. G., Chidiac, T. A., Flaherty, L. E., Zha, Y., Othus, M. K. D., Ribas, A., Sondak, V. K., Gajewski, T. F., et al. (2014) · Cancer · doi:10.1002/cncr.29055 · Cited by 91
Caliceti, C., Nigro, P., Rizzo, P., & Ferrari, R. (2014) · BioMed Research International · doi:10.1155/2014/318714 · Cited by 91
Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis
Nieszporek, A., Skrzypek, K., Adamek, G., & Majka, M. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2019_2899 · Cited by 91
Li, W., Cao, L., Chen, X., Lei, J., & Ma, Q. (2015) · Oncology Reports · doi:10.3892/or.2015.4504 · Cited by 88
The regulation of apoptosis by Numb/Notch signaling in the serotonin lineage ofDrosophila
Lundell, M. J., Lee, H.-K., Pérez, E., & Chadwell, L. V. (2003) · Development · doi:10.1242/dev.00593 · Cited by 87
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1
Kohlhaas, V., Blakemore, S. J., Al-Maarri, M., Nickel, N., Pal, M., Roth, A., Hövelmeyer, N., Schäfer, S. C., Knittel, G., Lohneis, P., et al. (2021) · Blood · doi:10.1182/blood.2020005734 · Cited by 87
Chen, Y., Bieber, M. M., & Teng, N. N. H. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22015 · Cited by 86
Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer
Xie, H., Paradise, B. D., Ma, W. W., & Fernández-Zapico, M. E. (2019) · Cells · doi:10.3390/cells8050394 · Cited by 86
Kumar, S., Nandi, A., Singh, S., Regulapati, R., Li, N., Tobias, J. W., Siebel, C. W., Blanco, M. A., Klein–Szanto, A. J., Lengner, C. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20664-5 · Cited by 86
Liu, Q., Zhu, H., Tiruthani, K., Shen, L., Chen, F., Gao, K., Zhang, X., Hou, L., Wang, D., Liu, R., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07384 · Cited by 83
Ilmer, M., Boiles, A. R., Regel, I., Yokoi, K., Michalski, C. W., Wistuba, I. I., Rodriguez‐Canales, J., Alt, E., & Vykoukal, J. V. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1327 · Cited by 82
Irvine, D. A., Zhang, B., Kinstrie, R., Tarafdar, A., Morrison, H., Campbell, V. L., Moka, H. A., Ho, Y., Nixon, C., Manley, P. W., et al. (2016) · Scientific Reports · doi:10.1038/srep25476 · Cited by 81
Targeting Notch to overcome radiation resistance
Yahyanejad, S., Theys, J., & Vooijs, M. (2015) · Oncotarget · doi:10.18632/oncotarget.6714 · Cited by 79
Ji (2010) · Oncology Reports · doi:10.3892/or_00000712 · Cited by 74
Cao, L., Xiao, X., Lei, J., Duan, W., Ma, Q., & Li, W. (2016) · Oncology Reports · doi:10.3892/or.2016.4709 · Cited by 74
CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis
Mohapatra, P., Shriwas, O., Mohanty, S., Ghosh, A., Smita, S., Kaushik, S. R., Arya, R. K., Rath, R., Majumdar, S. K. D., Muduly, D. K., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143643 · Cited by 74
The Notch-2 Gene Is Regulated by Wnt Signaling in Cultured Colorectal Cancer Cells
Ungerbäck, J., Elander, N., Grünberg, J. R., Sigvardsson, M., & Söderkvist, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017957 · Cited by 71
Gan, G. N., Eagles, J. R., Keysar, S. B., Wang, G., Glogowska, M. J., Altunbas, C., Anderson, R. T., Le, P. N., Morton, J. J., Frederick, B. A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1346 · Cited by 71
Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer
Liu, Y., Hsu, H., Tseng, K.-C., Chen, H., & Chen, S. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.08.001 · Cited by 70
NOTCH1 Inhibits Activation of ATM by Impairing the Formation of an ATM-FOXO3a-KAT5/Tip60 Complex
Adamowicz, M., Vermezovic, J., & di Fagagna, F. D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.038 · Cited by 69
Wnts are dispensable for differentiation and self-renewal of adult murine hematopoietic stem cells
Kabiri, Z., Numata, A., Kawasaki, A., Edison, Tenen, D. G., & Virshup, D. M. (2015) · Blood · doi:10.1182/blood-2014-09-598540 · Cited by 68
Rahman, M. T., Nakayama, K., Rahman, M., Katagiri, H., Katagiri, A., Ishibashi, T., Ishikawa, M., Iida, K., Nakayama, S., Otsuki, Y., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcpkdlrq8f3ewns · Cited by 66
Veeraraghavalu, K., Subbaiah, V. K., Srivastava, S., Chakrabarti, O., Syal, R., & Krishna, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7889-7898.2005 · Cited by 65
Sabbatino, F., Wang, Y., Wang, X., Flaherty, K. T., Yu, L. D., Pépin, D., Scognamiglio, G., Pepe, S., Kirkwood, J. M., Cooper, Z. A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1878 · Cited by 65
Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways
Oren, O., & Smith, B. D. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9691-3 · Cited by 65
Nagaraj, A. B., Knarr, M., Sekhar, S. C., Connor, R. S., Joseph, P. L., Kovalenko, O., Fleming, A., Surti, A., Nurmemmedov, E., Beltrame, L., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2041 · Cited by 65
Wang, K., Chen, D., Qian, Z., et al. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0491-x · Cited by 64
β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma
Zinke, J., Schneider, F. T., Harter, P. N., Thom, S., Ziegler, N., Toftgård, R., Plate, K. H., & Liebner, S. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0294-4 · Cited by 63
Dai, G., Deng, S., Guo, W., Yu, L., Yang, J., Zhou, S., & Gao, T. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22873 · Cited by 63
Khanam, T., Sandmann, S., Seggewiß, J., Ruether, C., Zimmermann, M., Norvil, A. B., Bartenhagen, C., Randau, G., Mueller, S., Herbrueggen, H., et al. (2020) · Blood · doi:10.1182/blood.2020005381 · Cited by 63
Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide
Melamed, J. R., Morgan, J. T., Ioele, S. A., Gleghorn, J. P., Sims‐Mourtada, J., & Day, E. S. (2018) · Oncotarget · doi:10.18632/oncotarget.25467 · Cited by 60
Pò, A., Citarella, A., Catanzaro, G., Besharat, Z. M., Trocchianesi, S., Gianno, F., Sabato, C., Moretti, M., Smaele, E. D., Vacca, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70871-9 · Cited by 60
Bousquet, E., Bernardo, S., Papon, L., Mancini, M., Fabbrizio, E., Goussard, M., Ferrer, I., Giry, A., Quantin, X., Pujol, J.-L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126896 · Cited by 59
Zhao, Y., Yi, J., Tao, L.-L., Huang, G.-C., Chu, X., Song, H.-Z., & Chen, L.-B. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0466-4 · Cited by 58
Tibes, R., Al‐Kali, A., Oliver, G. R., Delman, D. H., Hansen, N., Bhagavatula, K., Jayaram, M., Rakhshan, F., Wood, T., Foran, J. M., et al. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0211-8 · Cited by 57
Scarborough, H. A., Helfrich, B. A., Casás‐Selves, M., Schuller, A. G., Grosskurth, S. E., Kim, J., Tan, A. C., Chan, D. C. F., Zhang, Z., Zaberezhnyy, V., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1179 · Cited by 57
Li, D., Zhao, C., Ding, H., Wu, Q., Ren, T., Wang, J., Chen, C., & Zhao, Q. (2018) · Cell Proliferation · doi:10.1111/cpr.12480 · Cited by 56
Kong, Y., Peng, Y., Liu, Y., Xin, H., Zhan, X., & Tan, W. (2015) · Stem Cells · doi:10.1002/stem.1955 · Cited by 55
Notch controls generation and function of human effector CD8+ T cells
Kuijk, L. M., Verstege, M. I., Rekers, N. V., Bruijns, S. C. M., Hooijberg, E., Roep, B. O., de Gruijl, T. D., van Kooyk, Y., & Unger, W. W. J. (2013) · Blood · doi:10.1182/blood-2012-07-442962 · Cited by 55
Thomas, W. D., Chen, J., Gao, Y. R., Cheung, B. B., Koach, J., Sekyere, E. O., Norris, M. D., Haber, M., Ellis, T., Wainwright, B. J., et al. (2009) · Oncogene · doi:10.1038/onc.2009.3 · Cited by 53
Huang, C., Cheng, S.-H., Wu, C., Li, W., Wang, J.-S., Kung, M., Chu, T., Huang, S., Feng, C.-T., Huang, S., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0658-5 · Cited by 52
Xie, Y., Liu, J., Jiang, H., Wang, J., Li, X., Wang, J., Zhu, S., Guo, J. R., Li, T., Zhong, Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1037-6 · Cited by 52
WNT Signaling in Hematological Malignancies
Frenquelli, M., & Tonon, G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.615190 · Cited by 50
Long, J., Yang, C., Zheng, Y., Loughran, P., Guang, F., Li, Y., Liao, H., Scott, M. J., Tang, D., Billiar, T. R., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc5447 · Cited by 48
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
Jin, X., Spöttl, G., Maurer, J., Nölting, S., & Auernhammer, C. J. (2020) · Cancers · doi:10.3390/cancers12020345 · Cited by 47
Khan, M. A., Srivastava, S. K., Zubair, H., Patel, G. K., Arora, S., Khushman, M. M., Carter, J. E., Gorman, G. S., Singh, S., & Singh, A. P. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011748 · Cited by 47
Deregulated Notch and Wnt signaling activates early-stage myeloid regeneration pathways in leukemia
Kang, Y.-A., Pietras, E. M., & Passegue, E. A. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190787 · Cited by 45
Sun, J., Ma, Q., Li, B., Wang, C., Mo, L., Zhang, X., Tang, F., Wang, Q., Xiao-ling, Y. A. N., Yao, X., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03113-5 · Cited by 45
Alonso, S., Hernandez, D., Chang, Y., Gocke, C., McCray, M. E., Varadhan, R., Matsui, W. H., Jones, R. J., & Ghiaur, G. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88152 · Cited by 44
The Wnt inhibitor LGK-974 enhances radiosensitivity of HepG2 cells by modulating Nrf2 signaling
Tian, D., Shi, Y., Chen, D., Liu, Q., & Fan, F. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4042 · Cited by 43
Guo, Y., Zhang, K., Cheng, C., Ji, Z., Wang, X., Wang, M., Chu, M., Tang, D. G., Zhu, H. H., & Gao, W. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0913 · Cited by 43
Ding, J., Zhou, X.-T., Zou, H.-Y., & Wu, J. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.34 · Cited by 42
The Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in Human Cancer
Meng, E., Hanna, A., Samant, R. S., & Shevde, L. A. (2015) · Cancers · doi:10.3390/cancers7030839 · Cited by 42
Wnt3a promotes radioresistance via autophagy in squamous cell carcinoma of the head and neck
Jing, Q., Guo, L., Chen, X., Liu, C., Lu, S., Zheng, H. S., Ma, H., Qin, Y., Zhang, D., Zhang, S., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14394 · Cited by 42
Li, H., Zhang, W., Niu, C., Lin, C., Wu, X., Jian, Y., Li, Y., Ye, L., Dai, Y., Ouyang, Y., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32293 · Cited by 41
Self-citationLu, X., Wang, Z., Huang, H., & Wang, H. (2020) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13050 · Cited by 40
Maml1 acts cooperatively with Gli proteins to regulate sonic hedgehog signaling pathway
Quaranta, R., Pelullo, M., Zema, S., Nardozza, F., Checquolo, S., Lauer, D. M., Bufalieri, F., Palermo, R., Felli, M. P., Vacca, A., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.326 · Cited by 39
Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1
Shah, D., Wyatt, D. L., Baker, A. T., Simms, P. E., Peiffer, D. S., Fernandez, M., Rakha, E. A., Green, A. R., Filipovic, A., Miele, L., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1952 · Cited by 39
Wan, H., Li, Z., Wang, H., Cai, F., & Wang, L. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02484-7 · Cited by 37
Hua, Y., Zhang, K., Sheng, J., Ning, Z., Li, Y., Shi, W., & Liu, L. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119205 · Cited by 36
Hedgehogs as Negative Regulators of the Cell Cycle
Neumann, C. J. (2005) · Cell Cycle · doi:10.4161/cc.4.9.1999 · Cited by 35
Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling
Wahafu, A., Xu, D., Wu, W., Xiang, J., Ma, X., Xie, W., Bai, X., Wang, M., & Wang, J. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01750-4 · Cited by 35
Colombo, M., Garavelli, S., Mazzola, M., Platonova, N., Giannandrea, D., Colella, R., Apicella, L., Lancellotti, M., Lesma, E. A., Ancona, S., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.221077 · Cited by 33
Ruggiero, C. F., Malpicci, D., Fattore, L., Madonna, G., Vanella, V., Mallardo, D., Liguoro, D., Salvati, V., Capone, M., Bedogni, B., et al. (2019) · Cancers · doi:10.3390/cancers11101425 · Cited by 32
Up-regulation of GLI1 in vincristine-resistant rhabdomyosarcoma and Ewing sarcoma
Yoon, J. W., Lamm, M. L. G., Chandler, C., Iannaccone, P. M., & Walterhouse, D. O. (2020) · BMC Cancer · doi:10.1186/s12885-020-06985-0 · Cited by 32
High expression of miR-9 in CD133+glioblastoma cells in chemoresistance to temozolomide
Munoz, J. L., Rodriguez‐Cruz, V., & Rameshwar, P. (2015) · Journal of Cancer Stem Cell Research · doi:10.14343/jcscr.2015.3e1003 · Cited by 31
GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer
Yu, B., Gu, D., Zhang, X., Li, J., Liu, B., & Xie, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16174 · Cited by 31
Li, B., Jia, Z., Wang, T., Wang, W., Zhang, C., Chen, P., Ma, K., & Zhou, C. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23390 · Cited by 29
Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer
Steg, A. D., Burke, M. R., Amm, H. M., Katre, A. A., Dobbin, Z. C., Jeong, D. H., & Landen, C. N. (2014) · Oncotarget · doi:10.18632/oncotarget.2295 · Cited by 29
Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition
Qiu, S., Deng, L., Bao, Y., Jin, K., Tu, X., Li, J., Liao, X., Liu, Z., Yang, L., & Wei, Q. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000659 · Cited by 29
Ribeiro, J. H., Hauser‐Davis, R. A., Saggioro, E. M., Correia, F. V., Sales, S. F., Soares, L. O. S., Lima, L. D. R., Moura‐Neto, V., Lopes, G. P. D. F., & Spohr, T. C. L. S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29274 · Cited by 28
Li, H., Jiang, W., Liu, X.-N., Yuan, L., Li, T., Li, S., Xu, S., Zhang, W., Gao, H.-L., Han, X., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01407-8 · Cited by 28
Ghoshal, A., Goswami, U., Sahoo, A. K., Chattopadhyay, A., & Ghosh, S. S. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00305 · Cited by 25
Martinez-Font, E., Pérez-Capó, M., Ramos, R. F., Felipe‐Abrio, I., de España, C. G., Luna, P., Terrasa, J., Martín‐Broto, J., Vögler, O., Alemany, R., et al. (2020) · Cancers · doi:10.3390/cancers12092556 · Cited by 25
Li, D., Li, T., Shang, Z., Zhao, L., Xu, Q., Tan, J., Qin, Y., Zhang, Y., Cao, Y., Wang, N., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0108-z · Cited by 23
Kasiri, S., Chen, B., Wilson, A. N., Reczek, A., Mazambani, S., Gadhvi, J. G., Noel, E., Marriam, U., Mino, B., Lü, W., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1224-5 · Cited by 22
Mazzotta, M., Filetti, M., Occhipinti, M. A., Marinelli, D., Scalera, S., Terrenato, I., Sperati, F., Pallocca, M., Rizzo, F., Gelibter, A. J., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000946 · Cited by 22
Wang, Q., Liao, J., He, Z., Su, Y., Lin, D., Xu, L., Xu, H., & Lin, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s258896 · Cited by 21
Cited by
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Xue, C., Chu, Q., Shi, Q., Zeng, Y., Lu, J., & Li, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02142-w · Cited by 281
Self-citationCitarella, A., Catanzaro, G., Besharat, Z. M., Trocchianesi, S., Barbagallo, F., Gosti, G., Leonetti, M., Di Fiore, A., Coppola, L., Autilio, T. M., et al. (2023) · Cancers · doi:10.3390/cancers15051471 · Cited by 27
Zhang, W., Zhang, K., Ma, Y., Song, Y., Qi, T., Xiong, G., Zhang, Y., Kan, C., Zhang, J., Han, F., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115344 · Cited by 22
Metadata
- Authors
- Kumar, V., Vashishta, M., Kong, L., Wu, X., Lu, J. J., Guha, C., & Dwarakanath, B. S.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2021-04-22
- Volume
- 9
- Pages
- 650772-650772
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3156935377
- Cited by
- 255
- References
- 211
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.